Clinical trial
Prospective Epidemiological Study Of The Prevalence Of HLA-B*5701
NCT00453440 · ViiV Healthcare, Industry · Completed
Key facts
| NCT number | NCT00453440 |
|---|---|
| Title | Prospective Epidemiological Study Of The Prevalence Of HLA-B*5701 |
| Official title | Prospective Epidemiological Study of the Prevalence of HLA-B*5701 in HIV-1 Infected UK Patients |
| Lead sponsor | ViiV Healthcare, Industry |
| Collaborators | GlaxoSmithKline Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | Infection, Human Immunodeficiency Virus |
| Intervention type | Procedure |
| Interventions | Cheek swab & blood test |
| Enrollment | 1,502 |
| Start date | Mar 20, 2007 |
| Primary completion | Aug 10, 2007 |
| Completion | Aug 10, 2007 |
| First posted | Mar 29, 2007 |
| Last update posted | Sep 12, 2017 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: